BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21864120)

  • 1. Perilobar nephrogenic rests and chromosome 22.
    Mdzin R; Phillips M; Edwards C; Murch A; Charles A
    Pediatr Dev Pathol; 2011; 14(6):485-92. PubMed ID: 21864120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonality and loss of heterozygosity of WT genes are early events in the pathogenesis of nephroblastomas.
    Guertl B; Ratschek M; Harms D; Jaenig U; Leuschner I; Poremba C; Hoefler G
    Hum Pathol; 2003 Mar; 34(3):278-81. PubMed ID: 12673563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse hyperplastic perilobar nephroblastomatosis.
    Vicens J; Iotti A; Lombardi MG; Iotti R; de Davila MT
    Pediatr Dev Pathol; 2009; 12(3):237-8. PubMed ID: 18597570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wilms tumor: an update.
    Al-Hussain T; Ali A; Akhtar M
    Adv Anat Pathol; 2014 May; 21(3):166-73. PubMed ID: 24713986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precursor lesions of Wilms tumor: clinical and biological implications.
    Beckwith JB
    Med Pediatr Oncol; 1993; 21(3):158-68. PubMed ID: 8383276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
    Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
    Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of MIB and BCL-2 in patients with nephrogenic rests with and without associated Wilms' tumors.
    Wünsch L; Flemming P; Glüer S
    Eur J Pediatr Surg; 2001 Apr; 11(2):105-9. PubMed ID: 11371029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precursor lesions of Wilms' tumor in Indian children: a multiinstitutional study.
    Mishra K; Mathur M; Logani KB; Kakkar N; Krishna A
    Cancer; 1998 Nov; 83(10):2228-32. PubMed ID: 9827730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic features of nephrogenic rests and nephroblastomatosis.
    Hennigar RA; O'Shea PA; Grattan-Smith JD
    Adv Anat Pathol; 2001 Sep; 8(5):276-89. PubMed ID: 11556536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity for the short arm of chromosome 7 in sporadic Wilms tumour.
    Grundy RG; Pritchard J; Scambler P; Cowell JK
    Oncogene; 1998 Jul; 17(3):395-400. PubMed ID: 9690521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperplastic perilobar nephroblastomatosis: long-term survival of 52 patients.
    Perlman EJ; Faria P; Soares A; Hoffer F; Sredni S; Ritchey M; Shamberger RC; Green D; Beckwith JB;
    Pediatr Blood Cancer; 2006 Feb; 46(2):203-21. PubMed ID: 15816029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.
    Grundy P; Telzerow P; Moksness J; Breslow NE
    Med Pediatr Oncol; 1996 Nov; 27(5):429-33. PubMed ID: 8926924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations.
    Beckwith JB
    Am J Med Genet; 1998 Oct; 79(4):268-73. PubMed ID: 9781906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaplastic nephrogenic rest.
    Argani P; Collins MH
    Am J Surg Pathol; 2006 Oct; 30(10):1339-41. PubMed ID: 17001170
    [No Abstract]   [Full Text] [Related]  

  • 16. Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor.
    Beckwith JB; Kiviat NB; Bonadio JF
    Pediatr Pathol; 1990; 10(1-2):1-36. PubMed ID: 2156243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor II messenger ribonucleic acid expression in Wilms tumor, nephrogenic rest, and kidney.
    Yun K; Molenaar AJ; Fiedler AM; Mark AJ; Eccles MR; Becroft DM; Reeve AE
    Lab Invest; 1993 Nov; 69(5):603-15. PubMed ID: 7504120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic findings in Wilms' tumour: a single institute study.
    MdZin R; Murch A; Charles A
    Pathology; 2010 Dec; 42(7):643-9. PubMed ID: 21080873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case of interstitial 12q deletion in association with Wilms tumor.
    Rapley EA; Hargrave D; Persinguhe N; Barfoot R; Moore I; Radford M; Stratton MR; Rahman N; Pritchard-Jones K
    Am J Med Genet; 2001 Dec; 104(3):246-9. PubMed ID: 11754052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes.
    Fukuzawa R; Anaka MR; Heathcott RW; McNoe LA; Morison IM; Perlman EJ; Reeve AE
    J Pathol; 2008 Aug; 215(4):377-87. PubMed ID: 18484682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.